1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Mid-Size Pharmaceutical – By Type

1.3.2        Europe Mid-Size Pharmaceutical – By Drug Development Type

1.3.3        Europe Mid-Size Pharmaceutical – By Formulation

1.3.4        Europe Mid-Size Pharmaceutical – By Therapy Area

1.3.5        Europe Mid-Size Pharmaceutical – By Country

2.           Mid-Size Pharmaceutical– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Mid-Size Pharmaceutical – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert Opinion

5.           Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Chronic Disorders

5.1.2        Increasing Product Approval and Launches

5.2         Market Restraints

5.2.1        Cutthroat Competition among Market Players

5.3         Market Opportunities

5.3.1        Rising Number of Healthcare Start-ups

5.4         Future Trends

5.4.1        Greater Focus on R&D

5.5         Impact Analysis

6.           Mid-Size Pharmaceutical Market– Europe Analysis

6.1         Europe Mid-Size Pharmaceutical Market Revenue Forecast and Analysis

7.           Europe Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type

7.1         Overview

7.2         Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

7.3         Prescription

7.3.1        Overview

7.3.2        Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Over-the-Counter (OTC)

7.4.1        Overview

7.4.2        Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Mid-Size Pharmaceutical Market Analysis – By Drug Development Type

8.1         Overview

8.2         Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

8.3         In-House

8.3.1        Overview

8.3.2        In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Outsource

8.4.1        Overview

8.4.2        Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Mid-Size Pharmaceutical Market – By Formulation

9.1         Overview

9.2         Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

9.3         Tablets and Capsules

9.3.1        Overview

9.3.2        Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Injectables

9.4.1        Overview

9.4.2        Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Sprays

9.5.1        Overview

9.5.2        Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Formulations

9.6.1        Overview

9.6.2        Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Mid-Size Pharmaceutical Market – By Therapy Class

10.1      Overview

10.2      Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

10.3      Cardiovascular Diseases

10.3.1     Overview

10.3.2     Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Pain Management

10.4.1     Overview

10.4.2     Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Diabetes

10.5.1     Overview

10.5.2     Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Cancer

10.6.1     Overview

10.6.2     Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Other Diseases

10.7.1     Overview

10.7.2     Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.        Europe Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.1     Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)

11.1.1.1       Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4       Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5       Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.6       Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2       France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4       France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5       France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.6       France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3       UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4       UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5       UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.6       UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4       Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3       Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.4       Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.5       Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.6       Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5       Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.1       Overview

11.1.1.5.2       Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.3       Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.4       Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.5       Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.6       Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6       Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3       Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.4       Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.5       Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.6       Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

12.        Mid-Size Pharmaceutical Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      DAIICHI SANKYO COMPANY LIMITED

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Eisai Co., Ltd.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bausch Health Companies Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Regeneron Pharmaceuticals, Inc

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sun Pharmaceutical Industries Ltd

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Alexion Pharmaceuticals, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Mallinckrodt

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Endo Pharmaceuticals Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Les Laboratories Servier

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   UCB S.A.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 5.             France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 7.             France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 11.          UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 12.          UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 15.          Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 19.          Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 23.          Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done By Companies

Table 27.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Mid-Size Pharmaceutical Segmentation

Figure 2.           Europe Mid-Size Pharmaceutical Segmentation, By Country

Figure 3.           Europe Mid-Size Pharmaceutical Overview

Figure 4.           Over-the-Counter Segment Held Largest Share by Type in Europe Mid-Size Pharmaceutical Market

Figure 5.           Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Europe Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028

Figure 8.           Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

Figure 9.           Europe Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        Europe Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

Figure 12.        Europe In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

Figure 15.        Europe Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

Figure 20.        Europe Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Europe Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe: Mid-Size Pharmaceutical Market, by Key Country – Revenue (2021) (US$ Million)

Figure 26.        Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)

Figure 27.        Percentage of people aged 65+ reporting chronic diseases are as follows: (Source: European Commission (2019a), Joint report on health care)

Figure 28.        Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Growth Strategies Done by the Companies in the Market, (%)